USSTOCK.TODAY
Regular Market
Log in Sign up

BioHarvest Sciences Announces Commercial Readiness of Olive Cell Composition

Newsfile Corp. +1 ·

BHST
BHST BioHarvest Sciences Inc
$1.62 -2.41%
View chart & analysis →
  1. 1BioHarvest Sciences Inc. announced that its proprietary olive cell composition has reached the commercial readiness stage.
  2. 2The olive cell recorded up to a 37% reduction in intracellular lipid accumulation in HepG2 human liver cells compared to the control group in an oleic acid-induced steatosis model.
  3. 3The olive cell showed up to a 50% reduction in Type 1 collagen accumulation in LX-2 hepatic stellate cells compared to the control group in a TGF-beta1-induced fibrosis model.

So what's the key point?

The olive ingredient created by BioHarvest Sciences Inc. is ready to be sold as a product. This ingredient showed effects in reducing fat and collagen in liver cells by up to 50%.

Source Newsfile Corp. +1 · View original ↗

Related 3-line summaries

BioHaven (BHST) Pursues Dual Listing on Tel Aviv Stock Exchange Newsfile Corp. +2 · Sep 3BioHarvest signs exclusive 20-ton rare fragrance manufacturing and supply agreement Newsfile Corp. +2 · Aug 11Riot signs $9.1B, 20-year lease for 191MW AI at Rockdale Blockspace +6 · Aug 11
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news